0000899243-21-003963.txt : 20210201 0000899243-21-003963.hdr.sgml : 20210201 20210201212317 ACCESSION NUMBER: 0000899243-21-003963 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210128 FILED AS OF DATE: 20210201 DATE AS OF CHANGE: 20210201 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GOTTSCHALK ADRIAN CENTRAL INDEX KEY: 0001828724 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39634 FILM NUMBER: 21578681 MAIL ADDRESS: STREET 1: 100 BINNEY STREET STREET 2: SUITE 610 CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Foghorn Therapeutics Inc. CENTRAL INDEX KEY: 0001822462 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 500 TECHNOLOGY SQUARE STREET 2: SUITE 700 CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-586-3100 MAIL ADDRESS: STREET 1: 500 TECHNOLOGY SQUARE STREET 2: SUITE 700 CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-01-28 0 0001822462 Foghorn Therapeutics Inc. FHTX 0001828724 GOTTSCHALK ADRIAN 500 TECHNOLOGY SQUARE, STE 700 CAMBRIDGE MA 02139 1 1 0 0 See Remarks Stock Option (Right to Buy) 16.63 2021-01-28 4 A 0 300000 0.00 A 2031-01-27 Common Stock 300000 300000 D The options will vest as to 25% of the underlying shares of common stock on January 28, 2022, the first anniversary of the vesting commencement date, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter following such first anniversary until the option is fully vested. President & Chief Executive Officer /s/ Allan Reine, M.D., Attorney-in-Fact 2021-02-01